skip to content

Broker Views

Broker Forecast - Liberum Capital issues a broker note on GlaxoSmithKline PLC

04 October 2017 08:10

Liberum Capital today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1760p (from 1900p).

Story provided by StockMarketWire.com

Related Company: GSK

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?

-

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.